Pain Management Testing by Liquid Chromatography Tandem Mass Spectrometry

被引:5
作者
Bodor, Geza S. [1 ]
机构
[1] Univ Colorado, Dept Pathol, Anschutz Med Campus,Leprino Bldg,Room 229, Aurora, CO 80045 USA
关键词
Opiates; Opioids; Pain medication; LC-MSMS; Liquid chromatography; Tandem mass spectrometry; QUANTITATIVE ENZYMATIC-HYDROLYSIS; LC-MS/MS; ORAL FLUID; UNITED-STATES; HUMAN URINE; CONJUGATED METABOLITES; OPIOID OVERDOSE; ILLICIT DRUGS; RISK-FACTORS; QUANTIFICATION;
D O I
10.1016/j.cll.2018.05.005
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
For appropriate pain medication monitoring, the analytical method must be sensitive enough to detect the prescribed medication and metabolites at a sufficiently low concentration to recognize compliance, even with a low-dose prescription. The method must also provide excellent selectivity to identify simultaneously present drugs even with similar chemical structures. The analytical method should uncover common illicit drugs/nonprescribed medications. Traditional immunoassays cannot satisfy these criteria, but liquid chromatography tandem mass spectrometry can. It requires expensive instrumentation, careful test design, and extensive validation and produces a large amount of data that must be interpreted according to the clinical context.
引用
收藏
页码:455 / +
页数:17
相关论文
共 48 条
[1]  
[Anonymous], 2017, UND COST OP CRIS
[2]  
Athar Masood M, 2017, BASIC CLIN PHARM TOX
[3]   Sensitivity of an Opiate Immunoassay for Detecting Hydrocodone and Hydromorphone in Urine from a Clinical Population: Analysis of Subthreshold Results [J].
Bertholf, Roger L. ;
Johannsen, Laura M. ;
Reisfield, Gary M. .
JOURNAL OF ANALYTICAL TOXICOLOGY, 2015, 39 (01) :24-28
[4]   Clinical risk factors for death after release from prison in Washington State: a nested case-control study [J].
Binswanger, Ingrid A. ;
Stern, Marc F. ;
Yamashita, Traci E. ;
Mueller, Shane R. ;
Baggett, Travis P. ;
Blatchford, Patrick J. .
ADDICTION, 2016, 111 (03) :499-510
[5]   Mortality After Prison Release: Opioid Overdose and Other Causes of Death, Risk Factors, and Time Trends From 1999 to 2009 [J].
Binswanger, Ingrid A. ;
Blatchford, Patrick J. ;
Mueller, Shane R. ;
Stern, Marc F. .
ANNALS OF INTERNAL MEDICINE, 2013, 159 (09) :592-600
[6]  
Bodor GS, 2016, METHODS MOL BIOL, V1383, P223, DOI 10.1007/978-1-4939-3252-8_24
[7]   Systematic and comprehensive strategy for reducing matrix effects in LC/MS/MS analyses [J].
Chambers, Erin ;
Wagrowski-Diehl, Diane M. ;
Lu, Ziling ;
Mazzeo, Jeffrey R. .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2007, 852 (1-2) :22-34
[8]   Prevalence and disposition of drugs of abuse and opioid treatment drugs in oral fluid [J].
Cone, Edward J. ;
Clarke, Joe ;
Tsanaclis, Lolita .
JOURNAL OF ANALYTICAL TOXICOLOGY, 2007, 31 (08) :424-433
[9]   FORENSIC DRUG-TESTING FOR OPIATES .4. ANALYTICAL SENSITIVITY, SPECIFICITY, AND ACCURACY OF COMMERCIAL URINE OPIATE IMMUNOASSAYS [J].
CONE, EJ ;
DICKERSON, S ;
PAUL, BD ;
MITCHELL, JM .
JOURNAL OF ANALYTICAL TOXICOLOGY, 1992, 16 (02) :72-78
[10]   High Rates of Inappropriate Drug Use in the Chronic Pain Population [J].
Couto, Joseph E. ;
Romney, Martha C. ;
Leider, Harry L. ;
Sharma, Smiriti ;
Goldfarb, Neil I. .
POPULATION HEALTH MANAGEMENT, 2009, 12 (04) :185-190